2022 Revenues ($USD) : $17,725,000,000
2022 R&D spend : $847,000,000
2022 Number of Employees : 48,000
Fiscal Year End : 12/31/2021
Company CEO : Peter Arduini, GE Healthcare CEO

As it prepares to spin off as its own independent company early next year — keeping its old name — GE HealthCare has been turning to major partnership deals versus M&A to compete better. GE HealthCare said in January that it is collaborating with Boston Scientific on cardiac care in Southeast Asia. In April, there was news of a global commercial collaboration agreement with Elekta in the radiation oncology space — a move that could help it better compete with Siemens Healthineers. An announcement soon followed of a partnership with Medtronic to offer various products and services for the growing sector of ambulatory surgery centers (ASCs) and office-based labs (OBLs). In other news, the company released its next-generation Definium 656 HD X-ray system. –CN